Robert W. Postma, Director at Alaunos Therapeutics, Inc. (TCRT), bought 750,000 shares at $0.65 ($488K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.